Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Freya Biosciences ApS

Home Clinical Trial Sponsors and OrganizationsFreya Biosciences ApS

Freya Biosciences ApS

ACTIVE

Denmarkwww.freyabiosciences.comHolding

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

7

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

3

42.9%

Not Applicable

2

28.6%

Phase 1

1

14.3%

Trial Status Distribution

Completed

3

42.9%

Recruiting

4

57.1%

Clinical Trials

Trials sponsored by this organization (7)

Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embryo Transfer Cycle

Jul 202630 participants

Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial

Mar 2026120 participants

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)

May 202397 participants

Vaginal Microbiome and IVF Pregnancy Outcome

Mar 2022301 participants

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis

Oct 202134 participants

Phase 1 first-in-human, single and multiple dosing study of FB301 in healthy female subjects

89 participants

Chlorhexidine and/or metronidazole plus FB301 pre-treatment trial

120 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials7
Approvals
News

Back to Organizations